Radiation nephropathy.
Cohen EP, Robbins ME.
Semin Nephrol. 2003 Sep;23(5):486-99. doi: 10.1016/s0270-9295(03)00093-7.
Radiation nephropathy: Mechanisms of injury and recovery in a murine model.
Ahmad A, Shi J, Ansari S, Merscher S, Pollack A, Zeidan Y, Fornoni A, Marples B.
Radiother Oncol. 2023 Oct;187:109813. doi: 10.1016/j.radonc.2023.109813. Epub 2023 Jul 17.
The Potential Effects of Taurine in Mitigation of Radiation Nephropathy.
Ma N, Kato T, Isogai T, Gu Y, Yamashita T.
Adv Exp Med Biol. 2019;1155:497-505. doi: 10.1007/978-981-13-8023-5_46.
Radiation nephropathy: a review.
Robbins ME, Bonsib SM.
Scanning Microsc. 1995 Jun;9(2):535-60.
Treatment of radiation nephropathy with ACE inhibitors and AII type-1 and type-2 receptor antagonists.
Moulder JE, Fish BL, Cohen EP.
Curr Pharm Des. 2007;13(13):1317-25. doi: 10.2174/138161207780618821.
Mitigation of radiation injuries via suppression of the renin-angiotensin system: emphasis on radiation nephropathy.
Cohen EP, Fish BL, Moulder JE.
Curr Drug Targets. 2010 Nov;11(11):1423-9. doi: 10.2174/1389450111009011423.
Clinical aspects of radiation nephropathy.
Breitz H.
Cancer Biother Radiopharm. 2004 Jun;19(3):359-62. doi: 10.1089/1084978041425106.
Radiation nephropathy is not mitigated by antagonists of oxidative stress.
Cohen EP, Fish BL, Irving AA, Rajapurkar MM, Shah SV, Moulder JE.
Radiat Res. 2009 Aug;172(2):260-4. doi: 10.1667/RR1739.
A Combination of Iohexol Treatment and Ionizing Radiation Exposure Enhances Kidney Injury in Contrast-Induced Nephropathy by Increasing DNA Damage.
Fujino S, Sun J, Nakayama S, Horikoshi Y, Kinugasa Y, Ishida M, Sakai C, Ike T, Doi S, Masaki T, Tashiro S.
Radiat Res. 2022 Apr 1;197(4):384-395. doi: 10.1667/RADE-21-00178.1.
TOXIC NEPHROPATHY.
SCHREINER GE, MAHER JF.
Am J Med. 1965 Mar;38:409-49. doi: 10.1016/0002-9343(65)90149-x.
